A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1

Virologic Response at 48 th Week, in Patients Newly Diagnosed With HIV-1, After the Implementation of a Test and Treat Model of Care, in a Single Portuguese Center.

The purpose of this study is to determine the proportion of newly diagnosed participants with Human Immunodeficiency Virus (HIV)-1 (naive participants) with virologic response at Week 48-defined as HIV-1 Ribonucleic acid (RNA) less than (<) 50 copies/milliliter (mL) (Food And Drug Administration snapshot) - after the implementation of the Test & Treat model of care and in a historical cohort.

A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1

Recruitment

Summary

Participation Requirements

Description

Tracking Information